Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficacy of sacubitril‐valsartan and SGLT2 inhibitors in heart failure with reduced ejection fraction: A systematic review and meta‐analysis
Xingchun Mo, Ping Lü, Xiaojing Yang
Clinical Cardiology (2023) Vol. 46, Iss. 10, pp. 1137-1145
Open Access | Times Cited: 12

Showing 12 citing articles:

Novel Therapies for Right Ventricular Failure
Bibhuti B. Das
Current Cardiology Reports (2025) Vol. 27, Iss. 1
Closed Access
The Combined Empagliflozin and Sacubitril/Valsartan Therapy Attenuates Isoproterenol-Induced Heart Failure in Rats: Functional, Molecular, and Structural Insights
Maja Muric, Ivan Srejović, Jovana Novaković, et al.
Cardiovascular Drugs and Therapy (2025)
Closed Access
O Uso de Inibidores do Cotransportador Sódio-Glicose 2 (ISGLT2) nos Pacientes com Fração de Ejeção Reduzida: Uma Revisão Integrativa
Irving Gabriel Araújo Bispo, Guilherme Martins Chaves, Mariana Gonçalves Fernandes, et al.
ABC Heart Failure & Cardiomyopathy (2025) Vol. 5, Iss. 1
Open Access
The Use of Sodium-Glucose Cotransporter2 (SGLT2) Inhibitors in Patients with Reduced Ejection Fraction: An Integrative Review
Irving Gabriel Araújo Bispo, Guilherme Martins Chaves, Mariana Gonçalves Fernandes, et al.
ABC Heart Failure & Cardiomyopathy (2025) Vol. 5, Iss. 1
Closed Access
Mechanism and Treatment of Right Ventricular Failure Due to Pulmonary Hypertension in Children
Bibhuti B. Das
Children (2025) Vol. 12, Iss. 4, pp. 476-476
Open Access
Is It Time for Polypill in Heart Failure Therapy? Current Preference among Indian Cardiologists: A Cross-sectional Survey
Kamal Sharma, A. K. Pandey, Prafulla Kerkar, et al.
Journal of the Practice of Cardiovascular Sciences (2025) Vol. 11, Iss. 1, pp. 50-55
Open Access
Unlocking the Potential: Angiotensin Receptor Neprilysin and Sodium Glucose Co-Transporter 2 Inhibitors for Right Ventricle Dysfunction in Heart Failure
Bibhuti B. Das
Medicina (2024) Vol. 60, Iss. 7, pp. 1112-1112
Open Access | Times Cited: 3
Benefits of sacubitril/valsartan administration and physical training in cardiac rehabilitation: current trends and bibliometric analysis of the years 2015-2024
Diana Carina Iovanovici, Bombonica Gabriela Dogaru, Carmen Delia Nistor-Cseppento, et al.
Balneo and PRM Research Journal (2024) Vol. 15, Iss. Vol.15, no. 2, pp. 683-683
Open Access | Times Cited: 2
Circulating Cell-Free Nuclear DNAs Predicted an Improvement of Systolic Left Ventricular Function in Individuals with Chronic Heart Failure with Reduced Ejection Fraction
Tetiana A. Berezina, Oleksandr O. Berezin, Michael Lichtenauer, et al.
(2024)
Open Access | Times Cited: 1
The complex interplay between SGLT2 inhibitors and atrial fibrillation: mechanisms and clinical implications
Behzad Fahimi, Somayeh Beikmohammadi
Deleted Journal (2024) Vol. 1, Iss. 1, pp. 72-86
Open Access
Circulating Cell-Free Nuclear DNA Predicted an Improvement of Systolic Left Ventricular Function in Individuals with Chronic Heart Failure with Reduced Ejection Fraction
Tetiana A. Berezina, Oleksandr O. Berezin, Michael Lichtenauer, et al.
Cardiogenetics (2024) Vol. 14, Iss. 4, pp. 183-197
Open Access
The Complex Interplay Between SGLT2 Inhibitors and Atrial Fibrillation: Mechanisms and Clinical Implications
Behzad Fahimi, Somayeh Beikmohammadi
(2023)
Open Access | Times Cited: 1
Page 1

Scroll to top